These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 32298320)

  • 1. Interest in linkage to PrEP among people who inject drugs accessing syringe services; Miami, Florida.
    Jo Y; Bartholomew TS; Doblecki-Lewis S; Rodriguez A; Forrest DW; Tomita-Barber J; Oves J; Tookes HE
    PLoS One; 2020; 15(4):e0231424. PubMed ID: 32298320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PrEP awareness, eligibility, and interest among people who inject drugs in Baltimore, Maryland.
    Sherman SG; Schneider KE; Park JN; Allen ST; Hunt D; Chaulk CP; Weir BW
    Drug Alcohol Depend; 2019 Feb; 195():148-155. PubMed ID: 30639794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of syringe exchange programs and sexual identity in awareness of pre-exposure prophylaxis (PrEP) for male persons who inject drugs.
    Walters SM; Coston B; Neaigus A; Rivera AV; Starbuck L; Ramirez V; Reilly KH; Braunstein SL
    Int J Drug Policy; 2020 Mar; 77():102671. PubMed ID: 32092665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Relationship Between Polysubstance Injection Drug Use, HIV Risk Behaviors, and Interest in Pre-Exposure Prophylaxis (PrEP) Among People Who Inject Drugs in Rural West Virginia.
    Schneider KE; White RH; Musci RJ; O'Rourke A; Kilkenny ME; Sherman SG; Allen ST
    J Stud Alcohol Drugs; 2020 Nov; 81(6):740-749. PubMed ID: 33308403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low PrEP Awareness and Use Among People Who Inject Drugs, San Francisco, 2018.
    McFarland W; Lin J; Santos GM; Arayasirikul S; Raymond HF; Wilson E
    AIDS Behav; 2020 May; 24(5):1290-1293. PubMed ID: 31563984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Willingness to use HIV pre-exposure prophylaxis among community-recruited, older people who inject drugs in Washington, DC.
    Kuo I; Olsen H; Patrick R; Phillips G; Magnus M; Opoku J; Rawls A; Peterson J; Hamilton F; Kharfen M; Greenberg A
    Drug Alcohol Depend; 2016 Jul; 164():8-13. PubMed ID: 27177804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited Knowledge and Mixed Interest in Pre-Exposure Prophylaxis for HIV Prevention Among People Who Inject Drugs.
    Bazzi AR; Biancarelli DL; Childs E; Drainoni ML; Edeza A; Salhaney P; Mimiaga MJ; Biello KB
    AIDS Patient Care STDS; 2018 Dec; 32(12):529-537. PubMed ID: 30311777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Awareness of pre-exposure prophylaxis (PrEP) among women who inject drugs in NYC: the importance of networks and syringe exchange programs for HIV prevention.
    Walters SM; Reilly KH; Neaigus A; Braunstein S
    Harm Reduct J; 2017 Jun; 14(1):40. PubMed ID: 28662716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syringe disposal among people who inject drugs before and after the implementation of a syringe services program.
    Levine H; Bartholomew TS; Rea-Wilson V; Onugha J; Arriola DJ; Cardenas G; Forrest DW; Kral AH; Metsch LR; Spencer E; Tookes H
    Drug Alcohol Depend; 2019 Sep; 202():13-17. PubMed ID: 31280002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Associated with Awareness of Pre-exposure Prophylaxis for HIV Among Persons Who Inject Drugs in Philadelphia: National HIV Behavioral Surveillance, 2015.
    Roth A; Tran N; Piecara B; Welles S; Shinefeld J; Brady K
    AIDS Behav; 2019 Jul; 23(7):1833-1840. PubMed ID: 30267367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study protocol for an efficacy trial of the "PrEP for Health" intervention to increase HIV PrEP use among people who inject drugs.
    Bazzi AR; Bordeu M; Baumgartner K; Sproesser DM; Bositis CM; Krakower DS; Mimiaga MJ; Biello KB
    BMC Public Health; 2023 Mar; 23(1):513. PubMed ID: 36932369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serious Mental Illness Among Young People Who Inject Drugs: An Assessment of Injection Risks and Healthcare Use.
    Adams M; Sionean C; Broz D; Lewis R; Wejnert C;
    J Infect Dis; 2020 Sep; 222(Suppl 5):S401-S409. PubMed ID: 32877554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Providing medication for opioid use disorder and HIV pre-exposure prophylaxis at syringe services programs via telemedicine: a pilot study.
    McKellar MS; Des Marais AC; Chen H; Choi Y; Lilly R; Ayers D; Bennett J; Kestner L; Perry B; Poley S; Corneli A; Meade CS; Sachdeva N
    Harm Reduct J; 2024 Mar; 21(1):69. PubMed ID: 38532395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Take services to the people": strategies to optimize uptake of PrEP and harm reduction services among people who inject drugs in Uganda.
    Kamusiime B; Beima-Sofie K; Chhun N; Nalumansi A; Nalukwago GK; Kasiita V; Twesige CC; Kansiime R; Muwonge TR; Kyambadde P; Kadama H; Mudiope P; Glick S; Lambdin B; Mujugira A; Heffron R
    Addict Sci Clin Pract; 2024 Feb; 19(1):13. PubMed ID: 38395940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical Providers and Harm Reduction Views on Pre-Exposure Prophylaxis for HIV Prevention Among People Who Inject Drugs.
    Hershow RB; Gonzalez M; Costenbader E; Zule W; Golin C; Brinkley-Rubinstein L
    AIDS Educ Prev; 2019 Aug; 31(4):363-379. PubMed ID: 31361517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceptions of people who inject drugs towards HIV pre-exposure prophylaxis in Australia.
    Read P; Chronister KJ; Kostovski C; Harrod ME; Salmon A; Jauncey M
    Sex Health; 2019 Aug; 16(4):383-388. PubMed ID: 31203837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring Acceptability and Preferences for Implementation of Pre-Exposure Prophylaxis (PrEP) Using Conjoint Analysis: An Application to Primary HIV Prevention Among High Risk Drug Users.
    Shrestha R; Karki P; Altice FL; Dubov O; Fraenkel L; Huedo-Medina T; Copenhaver M
    AIDS Behav; 2018 Apr; 22(4):1228-1238. PubMed ID: 28695388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of Potential Discriminatory HIV Pre-Exposure Prophylaxis (PrEP) Prescribing Practices for People Who Inject Drugs Among a Small Percentage of Providers in the U.S.
    Pleuhs B; Mistler CB; Quinn KG; Dickson-Gomez J; Walsh JL; Petroll AE; John SA
    J Prim Care Community Health; 2022; 13():21501319211063999. PubMed ID: 35068243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary Care Physicians' Willingness to Prescribe HIV Pre-exposure Prophylaxis for People who Inject Drugs.
    Edelman EJ; Moore BA; Calabrese SK; Berkenblit G; Cunningham C; Patel V; Phillips K; Tetrault JM; Shah M; Fiellin DA; Blackstock O
    AIDS Behav; 2017 Apr; 21(4):1025-1033. PubMed ID: 27896552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuing Low Awareness and Use of Pre-exposure Prophylaxis (PrEP) for HIV among People Who Inject Drugs (PWID), San Francisco, 2022.
    Suprasert B; Tate M; Reagan D; Ruiz R; Gao K; McNaughton K; Miller K; Marr A; Taylor KD; Wilson EC; McFarland W
    AIDS Behav; 2024 Jun; 28(6):2089-2100. PubMed ID: 38526638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.